20 Peptides Ranked: Which Ones Actually Have Evidence Behind Them
Dr. Ashley Froese is walkthrough of the 20 most discussed peptides in clinical practice is one of the best single resources for anyone trying to make sense of the peptide space. The field is crowded with compounds, each surrounded by varying levels of hype, research, and confusion. Having a physician break down each one by category, evidence level, and practical application cuts through the noise in a way that forum threads and supplement company marketing never will.
Here is the landscape as she lays it out, organized by what they do and how strong the evidence actually is.
The Healing and Recovery Peptides
BPC-157 leads this category and for good reason. It has the broadest body of animal research showing tissue repair effects across tendons, gut lining, muscles, and nerves. The mechanism centers on angiogenesis, or new blood vessel formation, which supports healing by improving nutrient delivery to damaged tissue. Hundreds of animal studies back it up. The limitation is zero published human clinical trials, which means every claim about human outcomes is extrapolated from rats or based on anecdotal reports.
TB-500 (thymosin beta-4 fragment) complements BPC-157 through a different mechanism. It promotes cell migration by regulating actin, the structural protein inside cells that enables movement. Where BPC-157 builds the roads (blood vessels), TB-500 mobilizes the workforce (repair cells). This is why practitioners commonly stack them together for injury recovery.
KPV is a newer entry in the healing category. It is a fragment of alpha-melanocyte-stimulating hormone with anti-inflammatory properties. Early research suggests it may help with inflammatory bowel conditions by reducing gut inflammation through a different pathway than BPC-157. The evidence base is thinner than BPC-157, but the mechanism is interesting and distinct enough to warrant attention.
GHK-Cu (copper peptide) has solid research for wound healing and skin repair. It is naturally produced in your body and declines with age. Topical GHK-Cu has the most evidence behind it, with studies showing improved wound healing, increased collagen production, and skin tightening effects. The injectable form is less well-studied but gaining popularity in the anti-aging space.
The Growth Hormone Secretagogues
These peptides stimulate your pituitary gland to produce more growth hormone. They are popular among people interested in body composition improvement, recovery, anti-aging, and sleep quality.
CJC-1295 combined with Ipamorelin is arguably the most established secretagogue stack. CJC-1295 stimulates growth hormone-releasing hormone (GHRH), while Ipamorelin is a ghrelin mimetic that acts on a different receptor. Together, they produce a pulsatile release of growth hormone that more closely mimics natural patterns than exogenous HGH injections. Dr. Froese notes this combination has a favorable safety profile compared to direct growth hormone administration.
Tesamorelin is FDA-approved for HIV-associated lipodystrophy, giving it a level of clinical validation that most peptides lack. It reduces visceral fat and has been studied in controlled human trials. Its off-label use for general body composition improvement is growing, and the existing human data provides more confidence than we have for most peptides.
MK-677 (ibutamoren) is technically not a peptide but gets included in these discussions because it is an oral growth hormone secretagogue. The convenience of a pill versus injections makes it popular, but Dr. Froese raises concerns about its tendency to increase appetite and insulin resistance with chronic use. It is a trade-off that needs to be weighed carefully.
The Immune and Anti-Inflammatory Peptides
Thymosin alpha-1 is the standout here. It is approved as a drug in over 30 countries for hepatitis B and C treatment and is used as an immune modulator. It enhances T-cell function, improves vaccine responses, and has been studied in various infection and cancer settings. The clinical data is more robust than for most peptides because it has gone through regulatory approval processes in multiple countries.
LL-37 is an antimicrobial peptide that your body produces as part of the innate immune system. Supplemental LL-37 has been explored for its ability to fight biofilm infections, which are bacterial communities that resist standard antibiotics. The clinical applications are still being defined, but the mechanism is genuinely novel and addresses a real gap in infection treatment.
Dr. Froese also covers selank and semax, which are synthetic peptides developed in Russia with nootropic and anxiolytic properties. Selank appears to modulate GABA receptors and has shown anti-anxiety effects in clinical studies. Semax enhances brain-derived neurotrophic factor (BDNF) and has been studied for cognitive enhancement and stroke recovery. Both have more human data than most peptides in Western markets, though the research was primarily conducted in Russian institutions.
The Weight Management Peptides
GLP-1 receptor agonists like semaglutide and tirzepatide dominate this category, but there are peptide-based approaches that work through different mechanisms. AOD 9604, a fragment of growth hormone, has been studied for fat reduction without the growth-promoting effects of full-length HGH. The evidence is mixed, with some studies showing modest fat loss and others showing no significant effect.
MOTS-c is a mitochondrial-derived peptide that has generated excitement for its ability to improve metabolic function and exercise capacity in animal models. It activates AMPK, the same pathway that metformin targets, and may improve insulin sensitivity and fat metabolism. Human studies are in early stages.
Practical Guidance: How to Navigate This Space
Dr. Froese is framework for evaluating peptides comes down to three questions. First, is there a plausible biological mechanism? If the proposed mechanism does not make biological sense, steer clear regardless of how many testimonials exist. Second, how strong is the evidence? FDA-approved peptides like thymosin alpha-1 and tesamorelin are at the top. Peptides with extensive animal data like BPC-157 are in the middle. Peptides with minimal research are at the bottom. Third, what is the risk-benefit calculation for your specific situation?
Quality sourcing is a repeated theme throughout her assessment. The peptide market is poorly regulated, and product quality varies enormously. Third-party testing, certificates of analysis, and purchasing from established compounding pharmacies or research suppliers are minimum requirements. The cheapest peptide on the market is almost certainly not the one you want injecting into your body.
Working with a knowledgeable practitioner matters. Peptide therapy is still in an early stage where individual experience and clinical judgment play a large role. A practitioner who has worked with dozens or hundreds of peptide patients can adjust protocols based on your response in ways that generic internet dosing guides cannot.
Start with the best-studied options first. If you are interested in healing, BPC-157 and TB-500 have the most data. If you are interested in growth hormone optimization, CJC-1295/Ipamorelin is the most established stack. If you are interested in immune function, thymosin alpha-1 has actual clinical validation. Working outward from the most evidence-supported options reduces your risk of wasting money on compounds that turn out to be ineffective.
The Peptide Selection Decision Tree
One of the most useful frameworks Dr. Froese provides is a simple decision tree for choosing which peptides to explore first based on your primary goal. If tissue healing and injury recovery is the goal, start with BPC-157 and consider adding TB-500 for enhanced effect. If growth hormone optimization for body composition and recovery is the goal, the CJC-1295/Ipamorelin combination is the most proven starting point. If immune support is the primary need, thymosin alpha-1 has the strongest clinical backing of any peptide in this category.
For people interested in multiple goals, she recommends a sequential approach rather than stacking everything at once. Start with the peptide that addresses your most pressing concern, run it for 6 to 12 weeks, assess the response, and then consider adding a second compound if needed. This approach lets you identify what each peptide is actually doing for you, which becomes impossible when you start five compounds simultaneously.
She also makes the important point that peptides work best in the context of optimized fundamentals. Sleep, nutrition, exercise, and stress management create the foundation that peptide therapy builds on. Using peptides to compensate for a terrible diet and no exercise is like adding a turbocharger to a car with flat tires. Fix the basics first, then explore peptide therapy as an enhancement on top of a solid health foundation.
The cost consideration is real too. A multi-peptide protocol from a compounding pharmacy can run $300 to $800 per month. Before investing that kind of money, make sure the free interventions (sleep hygiene, dietary protein, regular exercise) are dialed in. You will get more value from peptides when your body is already operating in a reasonably healthy state, and you might find that optimizing the basics resolves some of the issues you were planning to address with peptides.
The Regulatory Reality
The FDA has been tightening regulations on peptides, particularly around compounding pharmacies. Several peptides that were previously available through compounding have been restricted or placed on the FDA is bulk drug substances list under scrutiny. This regulatory pressure is unlikely to ease, and it may change which peptides are accessible and through what channels.
This regulatory context is not about peptides being dangerous. It is about the FDA asserting control over a market that grew faster than the regulatory framework could keep up with. Some of this is protective and ensures quality standards. Some of it is influenced by pharmaceutical industry pressure as peptide therapies compete with patented drugs.
Regardless of the politics, the practical implication is that access to certain peptides may change. If a specific peptide is part of your health strategy, having a relationship with a knowledgeable prescriber and a reputable compounding pharmacy gives you the best chance of maintaining access as regulations evolve.